| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Communities living with hepatitis must be central to the response to liver diseases in the Asia-Pacific region
|
Wingrove, Chris
|
|
|
5 |
2 |
p. 107-109
|
artikel
|
| 2 |
Core inhibitor therapy for chronic hepatitis B
|
Sonneveld, Milan J
|
|
|
5 |
2 |
p. 99-100
|
artikel
|
| 3 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 454–65
|
|
|
|
5 |
2 |
p. e1
|
artikel
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 907–08
|
|
|
|
5 |
2 |
p. e1
|
artikel
|
| 5 |
Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
|
Black, Christopher J
|
|
|
5 |
2 |
p. 117-131
|
artikel
|
| 6 |
Headway and hurdles in non-alcoholic fatty liver disease
|
The Lancet Gastroenterology & Hepatology,
|
|
|
5 |
2 |
p. 93
|
artikel
|
| 7 |
High-dose NSAIDs and pancreatitis after ERCP: more is not always better
|
Rana, Surinder Singh
|
|
|
5 |
2 |
p. 95-97
|
artikel
|
| 8 |
How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?
|
Wong, Grace Lai-Hung
|
|
|
5 |
2 |
p. 103-105
|
artikel
|
| 9 |
Liver disease in Canada: the scale of the problem
|
Burki, Talha K
|
|
|
5 |
2 |
p. 114-115
|
artikel
|
| 10 |
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
|
Sarin, Shiv K
|
|
|
5 |
2 |
p. 167-228
|
artikel
|
| 11 |
Minimally invasive gastrectomy: time to change practice?
|
Berlth, Felix
|
|
|
5 |
2 |
p. 97-98
|
artikel
|
| 12 |
Polyethylene glycol-based laxatives for chronic constipation
|
Akriche, Fatma
|
|
|
5 |
2 |
p. 110
|
artikel
|
| 13 |
Polyethylene glycol-based laxatives for chronic constipation – Authors' reply
|
Luthra, Pavit
|
|
|
5 |
2 |
p. 110-111
|
artikel
|
| 14 |
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial
|
Fogel, Evan L
|
|
|
5 |
2 |
p. 132-141
|
artikel
|
| 15 |
Research in Brief
|
Baker, Holly
|
|
|
5 |
2 |
p. 113
|
artikel
|
| 16 |
Restricting alcohol consumption to reduce liver disease in the Asia-Pacific region
|
Jiang, Heng
|
|
|
5 |
2 |
p. 105-107
|
artikel
|
| 17 |
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
|
Yuen, Man-Fung
|
|
|
5 |
2 |
p. 152-166
|
artikel
|
| 18 |
Successful control of ulcerative colitis
|
Hastings, Barbara
|
|
|
5 |
2 |
p. 116
|
artikel
|
| 19 |
Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial
|
Katai, Hitoshi
|
|
|
5 |
2 |
p. 142-151
|
artikel
|
| 20 |
Sustain, accelerate, innovate: the burden of liver disease and way forward in the WHO South-East Asia region
|
Singh, Poonam Khetrapal
|
|
|
5 |
2 |
p. 100-102
|
artikel
|
| 21 |
The Liver Meeting 2019
|
Feetham, Laura
|
|
|
5 |
2 |
p. 112
|
artikel
|
| 22 |
Time to act to make elimination of viral hepatitis a reality
|
Kasai, Takeshi
|
|
|
5 |
2 |
p. 102-103
|
artikel
|
| 23 |
Traditional treatments for irritable bowel syndrome: the state of our knowledge
|
Törnblom, Hans
|
|
|
5 |
2 |
p. 94-95
|
artikel
|
Tijdschrift beschrijving